Tenet Healthcare Corp. (NYSE: THC) reported Q2 EPS of ($0.27), which may not compare with the analyst estimate of $0.01. Revenue for the quarter came in at $4.04 billion versus the consensus estimate of $3.94 billion.

The second quarter of 2014 included a $92 million increase in pre-tax interest expense compared to the second quarter of 2013.

The Company’s Outlook range for Adjusted EBITDA for the third quarter of 2014 is $400 million to $450 million and earnings per share in a range of a loss of $0.30 per share to income of $0.21 per share. No revenue related to the California Provider Fee program is assumed in this third quarter Outlook. Electronic health records incentives are assumed to contribute approximately $5 million to the third quarter’s Adjusted EBITDA.

The Company raised its 2014 Adjusted EBITDA Outlook range to $1.85 billion to $1.95 billion.

For earnings history and earnings-related data on Tenet Healthcare Corp. (THC) click here.